Literature DB >> 20013167

Myocardial imaging with 99mTc-Tetrofosmin: Influence of post-stress acquisition time, regional radiotracer uptake, and wall motion abnormalities on the clinical result.

Assuero Giorgetti1, Annette Kusch, Mirta Casagranda, Irene D'Aragona Tagliavia, Paolo Marzullo.   

Abstract

BACKGROUND: We previously demonstrated that early (15', T1) post-stress myocardial imaging with Tetrofosmin could be more accurate than standard acquisitions (45', T2) in identifying coronary artery disease. METHODS AND
RESULTS: To clarify this phenomenon, 120 subjects (age 61 +/- 10 years) with both T1 and T2 scans were divided into Group 1 (53/120 pts) with more ischemia at T1 vs T2 imaging (T1-T2SDS > or = 3); Group 2 (67/120 pts) with similar results (T1-T2SDS < or = 2). Myocardial areas were categorized as control nonischemic, ischemic, and scarred on the basis of perfusion/contraction properties and coronary anatomy. In each area, regional myocardial count statistic and semiquantitative wall motion/thickening values were obtained. Analysis of T1 and T2 post-stress myocardial counts demonstrated a significant Tetrofosmin wash-out rate that was higher in Group 1 control nonischemic regions (15 +/- 8% vs 13.6 +/- 9.6%, P < .02), significantly lower in Group 1 ischemic regions (7 +/- 10% vs 12.2 +/- 9.5%, P < .0001), and comparable between scarred areas of the two groups (P = NS). Delta post-stress wall thickening (T1-T2) was lower in Group 1 ischemic regions (-4.5 +/- 9.15% vs -1.90 +/- 7.0%, P < .001) and comparable in both control nonischemic and scarred areas of the two groups (P = NS).
CONCLUSION: The clinical result of Tetrofosmin gated-SPECT can be influenced by the post-stress acquisition time because of ischemic-induced regional wall thickening abnormalities and the existence of a differential radiotracer myocardial wash-out.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013167     DOI: 10.1007/s12350-009-9172-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  26 in total

1.  Stunning and left ventricular function--how long is the ventricle knocked out? Left ventricular function correlated with ischemic burden and recovery time after stress.

Authors:  B A Kaufmann; M E Pfisterer; S Viswanathan; J Müller-Brand; M J Zellweger
Journal:  Int J Cardiol       Date:  2005-11-15       Impact factor: 4.164

2.  Cardiac stress-rest single-photon emission computed tomography with technetium 99m-labeled tetrofosmin: influence of washout kinetics on regional myocardial uptake values of the rest study with a 1-day protocol.

Authors:  G Schulz; E Ostwald; H J Kaiser; J vom Dahl; E Kleinhans; U Buell
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

3.  Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease.

Authors:  G Ambrosio; S Betocchi; L Pace; M A Losi; P Perrone-Filardi; A Soricelli; F Piscione; J Taube; F Squame; M Salvatore; J L Weiss; M Chiariello
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization.

Authors:  E A Platts; T L North; R D Pickett; J D Kelly
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

6.  Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria.

Authors:  A Younès; J A Songadele; J Maublant; E Platts; R Pickett; A Veyre
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

7.  Feasibility and diagnostic accuracy of a gated SPECT early-imaging protocol: a multicenter study of the Myoview Imaging Optimization Group.

Authors:  Assuero Giorgetti; Massimiliano Rossi; Mario Stanislao; Guido Valle; Pietro Bertolaccini; Alberto Maneschi; Raffaele Giubbini; Maria Luisa De Rimini; Marco Mazzanti; Mario Cappagli; Elisa Milan; Duccio Volterrani; Paolo Marzullo
Journal:  J Nucl Med       Date:  2007-09-14       Impact factor: 10.057

8.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

Authors:  D Jain; F J Wackers; J Mattera; M McMahon; A J Sinusas; B L Zaret
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

9.  Impact of regional ventricular function, geometry, and dobutamine stress on quantitative 99mTc-sestamibi defect size.

Authors:  A J Sinusas; Q Shi; P J Vitols; R C Fetterman; P Maniawski; B L Zaret; F J Wackers
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

10.  Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography.

Authors:  P Rigo; B Leclercq; R Itti; A Lahiri; S Braat
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

View more
  4 in total

1.  Impact of imaging protocol on left ventricular ejection fraction using gated-SPECT myocardial perfusion imaging.

Authors:  C Marcassa; R Giubbini; W Acampa; C Cittanti; O Djepaxhija; A Gimelli; A Kokomani; G Medolago; E Milan; R Sciagrà
Journal:  J Nucl Cardiol       Date:  2016-04-06       Impact factor: 5.952

2.  The right timing for post-ischemic stunning.

Authors:  Dominik C Benz; Oliver Gaemperli
Journal:  J Nucl Cardiol       Date:  2016-04-05       Impact factor: 5.952

3.  Do we really need to look at volumetric measurements with 99mTc single photon emission computed tomography (SPECT) myocardial perfusion imaging?

Authors:  Dominik C Benz; Andreas A Giannopoulos
Journal:  J Nucl Cardiol       Date:  2018-03-27       Impact factor: 5.952

4.  Accuracy of myocardial perfusion imaging in detecting multivessel coronary artery disease: A cardiac CZT study.

Authors:  Alessia Gimelli; Riccardo Liga; Valerio Duce; Annette Kusch; Alberto Clemente; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2016-02-03       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.